Skip to main content
Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
162.85
+4.85 (3.07%)
Mar 6, 2026, 4:00 PM EST

Novartis AG Revenue

In the year 2025, Novartis AG had annual revenue of $56.67B with 9.57% growth. Novartis AG had revenue of $13.86B in the quarter ending December 31, 2025, with 2.23% growth.

Revenue
56.67B
Revenue Growth
+9.57%
P/S Ratio
5.42
Revenue / Employee
752.97K
Employees
75,267
Market Cap
306.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202556.67B4.95B9.57%
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Glass House Brands 196.17M
Elite Pharmaceuticals 140.12M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 559.00K
Tian'an Technology Group 2.12M
Vaxart 148.20M
Revenue Rankings

Novartis AG News

More News